Rastegarpanah, Malihe http://orcid.org/0000-0003-4089-3387
Azadmanesh, Kayhan http://orcid.org/0000-0002-7165-9043
Negahdari, Babak http://orcid.org/0000-0001-7899-156X
Asgari, Yazdan http://orcid.org/0000-0001-6993-6956
Mazloomi, Mohammadali http://orcid.org/0000-0001-5370-3111
Funding for this research was provided by:
Tehran University of Medical Sciences and Health Services (97-01-87-37998)
Biotechnology Development Council of the Islamic Republic of Iran (970401)
Article History
Received: 4 February 2022
Accepted: 1 April 2022
First Online: 27 April 2022
Declarations
:
: The authors declare that they have no conflicts of interest.
: Human diploid lung fibroblast cell line MRC-5 (RRID: CVCL_RB14), adenocarcinomic human alveolar basal epithelial cells A549 (RRID: CVCL_VR66), human embryonic kidney 293 cells (RRID: CVCL_0045), immortal human cell line Hela (RRID: CVCL_0030), and human hepatocyte carcinoma cell line HepG2 (RRID: CVCL_0027) were obtained from the “American Type Culture Collection (ATCC)” and informed consent is not applicable.
: All procedures performed in this study involving human cell lines were in accordance with the ethical standards of the Medical Ethics Committee at the Tehran University of Medical Sciences (TUMS) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.